- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® Research Roundup: November 2018
Here are 5 interesting findings from the November 2018 issue of AJMC®.
Hi, I’m Christina Mattina for The American Journal of Managed Care®. Here are 5 findings from research published in the November issue.
A Randomized, Pragmatic, Pharmacist-Led Intervention Reduced Opioids Following Orthopedic Surgery
1. A pharmacist-led intervention that included mailed brochures and follow-up telephone calls post surgery successfully reduced opioid prescribing after hip replacement, but not knee replacement.
Patients' Adoption of and Feature Access Within Electronic Patient Portals
2. Patients who are racial minorities or older than 70 years are significantly less likely to access most online patient portal features, indicating that overreliance on these portals for patient engagement could exacerbate current disparities.
Cost of Pharmacotherapy for Opioid Use Disorders Following Inpatient Detoxification
3. The modest costs of medication management for opioid use are mainly driven by factors like medication costs and visit frequency, but some patients may experience cost-related barriers to treatment.
Impact of Dementia on Costs of Modifiable Comorbid Conditions
4. Fifteen comorbid conditions were more prevalent and more costly per person among Medicare beneficiaries with Alzheimer disease and other dementias than those without, indicating areas of focus for population health management efforts.
Overdose Risk for Veterans Receiving Opioids From Multiple Sources
5. Veterans who fill opioid prescriptions through the Veterans Health Administration and other pharmacies have higher odds of nonfatal opioid overdose and all-cause mortality than those who use VHA pharmacies only, highlighting the importance of care coordination.
To read all of these studies and more, visit AJMC.com.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
